The 25 country report has led to the creation of the International Neuroblastoma Risk Group Classification System, with the results published in two papers in the Journal of Clinical Oncology today.
Professor Pearson, alongside co-author Professor Susan Cohn at the University of Chicago are extremely optimistic about improving standards of care for all neuroblastoma patients. Professor Andrew Pearson comments:
“This tailored strategy will hopefully replace the existing ‘one size fits all’ approach utilised across the world. It streamlines the process for identifying what stage the disease is at and how aggressive it is, and clearly identifies how much treatment each child should receive.”
“In this way, we hope that children with neuroblastoma will receive the best possible chance of a cure, keeping the level of treatment and the associated side-effects to a minimum.”
The new strategy will be used by the International Neuroblastoma Risk Group (INRG) which represents paediatric oncologists treating neuroblastoma patients treated in Europe, Japan, the USA, Canada, and Australia.
Survival rates overall for children with cancer have improved dramatically in recent years. However, more than half of children with neuroblastoma will present the aggressive, high-risk disease, which is more likely to relapse and is linked with a poor rate of recovery.
“How neuroblastoma attacks the body varies dramatically in each patient and, up until now, it has been difficult to accurately predict the progression of the disease. With these systems, we will be able to choose appropriate treatments based on the evidence of relevant risk factors.” Professor Pearson says.
Neuroblastoma, a cancer of the developing nervous system, is one of the most common types of childhood cancers, causing 15 per cent of all childhood cancer deaths in the UK. Its different forms vary in severity: while some cases in young children disappear with minimal treatment, cases in older children can be relentlessly aggressive. Identifying the form is therefore crucial in planning appropriate treatment.
Bethany Hankin was diagnosed with aggressive neuroblastoma aged 18 months. Now 3 years old and in remission, her mother Katie Hankin is eager to see better information for doctors:
“The harsh reality is that neuroblastoma is one of the most aggressive childhood cancers, yet receives very little attention. During Bethany’s first course of treatment, we had been told parts of her diagnosis, but not the exact status of her disease. Neuroblastoma is such an unpredictable disease, any research that helps doctors make a more informed diagnosis sooner can only be a blessing for families.”
This new research was funded by the William Guy Forbeck Research Foundation and Little Heroes Paediatric Cancer Research Foundation, and offers clearer direction for diagnosis and risk assessment for clinicians on a global level.
The first of the two papers proposes the International Neuroblastoma Risk Group (INRG) classification system. The paper focuses on the personalisation of treatment by classifying neuroblastoma based on 13 factors.
The second paper replaces the current four stage system of diagnosis of neuroblastoma based on a new International Neuroblastoma Risk Group Staging System (INRGSS.)
The importance of biodiversity in forests could increase due to climate change
17.11.2017 | Deutsches Zentrum für integrative Biodiversitätsforschung (iDiv) Halle-Jena-Leipzig
Win-win strategies for climate and food security
02.10.2017 | International Institute for Applied Systems Analysis (IIASA)
High-precision measurement of the g-factor eleven times more precise than before / Results indicate a strong similarity between protons and antiprotons
The magnetic moment of an individual proton is inconceivably small, but can still be quantified. The basis for undertaking this measurement was laid over ten...
Heat from the friction of rocks caused by tidal forces could be the “engine” for the hydrothermal activity on Saturn's moon Enceladus. This presupposes that...
The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.
Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....
The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.
Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...
Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.
That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...
15.11.2017 | Event News
15.11.2017 | Event News
30.10.2017 | Event News
24.11.2017 | Physics and Astronomy
24.11.2017 | Health and Medicine
24.11.2017 | Earth Sciences